• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征女性高雄激素血症的鉴别诊断。

Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.

作者信息

Rachoń D

机构信息

Department of Clinical and Experimental Endocrinology, Institute of Marine and Tropical Medicine, Medical University of Gdańsk, Poland.

出版信息

Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):205-9. doi: 10.1055/s-0031-1299765. Epub 2012 Mar 15.

DOI:10.1055/s-0031-1299765
PMID:22421986
Abstract

According to the Androgen Excess and Polycystic Ovary Syndrome Society (AE&PCOS), the main feature of PCOS is clinical hyperandrogenism or laboratory hyperandrogenaemia. Therefore, in diagnosing PCOS one must always exclude other causes of androgen excess. In a woman with hyperandrogenism, the diagnosis of PCOS can usually be made according to the patient's history and careful clinical examination. Signs of mild hyperandrogenaemia usually start after the menarche and cycles continue to be anovulatory in adult life. Non-classical congenital adrenal hyperplasia (NCCAH) can be another cause of hyperandrogenism with oligomenorrhea. This can be diagnosed in a patient with elevated basal or ACTH stimulated serum 17OH-progesterone (17-OHP) levels or in a case of a significant decrease in serum testosterone (TST) and dehydroepiandrosterone sulphate (DHEA-S) in a two day dexamethasone suppression test. Cushing's disease (ACTH producing pituitary adenoma) is a rare cause of hyperandrogenaemia in women with recent onset of hyperandrogenism. However, it must always be taken into the consideration in a patient with accompanying signs of hypercortisolism. It can usually be excluded by performing an overnight dexamethasone suppression test or the measurement of 24 h urinary free cortisol levels. Severe signs of hyperandrogenism which lead to virilization should always lead to the exclusion of androgen secreting tumors of ovarian or adrenal origin. These are very rare but should be always taken into the account in a patient with recent onset of severe signs of androgen excess and very high serum androgen levels. Mild signs of hyperandrogenaemia in a woman with recent oligomenorrhea should always lead to the exclusion of hyperprolactinaemia.

摘要

根据雄激素过多与多囊卵巢综合征协会(AE&PCOS)的说法,多囊卵巢综合征的主要特征是临床高雄激素血症或实验室高雄激素血症。因此,在诊断多囊卵巢综合征时,必须始终排除其他导致雄激素过多的原因。对于患有高雄激素血症的女性,通常可根据患者病史及仔细的临床检查来诊断多囊卵巢综合征。轻度高雄激素血症的体征通常在初潮后开始出现,成年后月经周期仍无排卵。非经典型先天性肾上腺皮质增生症(NCCAH)可能是高雄激素血症伴月经过少的另一个原因。这可通过基础或促肾上腺皮质激素(ACTH)刺激后血清17-羟孕酮(17-OHP)水平升高来诊断,或者通过两天地塞米松抑制试验中血清睾酮(TST)和硫酸脱氢表雄酮(DHEA-S)显著降低来诊断。库欣病(分泌ACTH的垂体腺瘤)是近期出现高雄激素血症的女性中高雄激素血症的罕见原因。然而,对于伴有皮质醇增多症体征的患者,必须始终考虑到这一情况。通常可通过进行过夜地塞米松抑制试验或测量24小时尿游离皮质醇水平来排除。导致男性化表现的严重高雄激素血症体征应始终排除卵巢或肾上腺来源的雄激素分泌肿瘤。这些情况非常罕见,但对于近期出现严重雄激素过多体征且血清雄激素水平极高的患者,应始终予以考虑。近期月经过少的女性出现轻度高雄激素血症体征时,应始终排除高催乳素血症。

相似文献

1
Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.多囊卵巢综合征女性高雄激素血症的鉴别诊断。
Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):205-9. doi: 10.1055/s-0031-1299765. Epub 2012 Mar 15.
2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
3
[Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].[多囊卵巢综合征患者的支持-间质细胞瘤(男性细胞瘤):临床、超声、激素及组织病理学评估]
Srp Arh Celok Lek. 2001 May-Jun;129 Suppl 1:51-5.
4
How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?患有库欣综合征的女性中,多囊卵巢和多囊卵巢综合征有多常见?
Clin Endocrinol (Oxf). 2000 Oct;53(4):493-500. doi: 10.1046/j.1365-2265.2000.01117.x.
5
Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.多囊卵巢综合征妇女的高雄激素血症在绝经后仍持续存在。
J Clin Endocrinol Metab. 2011 Mar;96(3):623-31. doi: 10.1210/jc.2010-0130. Epub 2010 Dec 22.
6
Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.改良地塞米松与促性腺激素释放激素激动剂(Dx-GnRHa)试验在评估多毛女性雄激素来源中的应用
Przegl Lek. 2000;57(7-8):393-6.
7
Investigation of patients with atypical or severe hyperandrogenaemia including androgen-secreting ovarian teratoma.对非典型或严重高雄激素血症患者的调查,包括分泌雄激素的卵巢畸胎瘤。
Eur J Endocrinol. 2010 Feb;162(2):213-20. doi: 10.1530/EJE-09-0576. Epub 2009 Nov 11.
8
Androgens in Cushing's Syndrome.库欣综合征中的雄激素。
Front Horm Res. 2019;53:77-91. doi: 10.1159/000494904. Epub 2019 Sep 9.
9
Hyperandrogenism in adolescent girls.
Endocr Dev. 2012;22:181-193. doi: 10.1159/000326688. Epub 2012 Jul 25.
10
Postmenopausal hyperandrogenism.绝经后高雄激素血症。
Climacteric. 2022 Apr;25(2):109-117. doi: 10.1080/13697137.2021.1915273. Epub 2021 May 14.

引用本文的文献

1
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women.内分泌学会女性雄激素过多评估临床实践指南
Clin Endocrinol (Oxf). 2025 Oct;103(4):540-566. doi: 10.1111/cen.15265. Epub 2025 May 13.
2
Impacts of Curcumin Supplementation on Cardiometabolic Risk Factors in Patients With Polycystic Ovary Syndrome: A Systematic Review and Dose-Response Meta-Analysis.补充姜黄素对多囊卵巢综合征患者心血管代谢危险因素的影响:一项系统评价和剂量反应荟萃分析。
Health Sci Rep. 2025 Mar 2;8(3):e70525. doi: 10.1002/hsr2.70525. eCollection 2025 Mar.
3
The Impact of Diet-Induced Weight Loss on Inflammatory Status and Hyperandrogenism in Women with Polycystic Ovarian Syndrome (PCOS)-A Systematic Review and Meta-Analysis.
饮食诱导的体重减轻对多囊卵巢综合征(PCOS)女性炎症状态和高雄激素血症的影响——一项系统评价和荟萃分析
J Clin Med. 2024 Aug 21;13(16):4934. doi: 10.3390/jcm13164934.
4
Depression, higher level of tension induction, and impaired coping strategies in response to stress in women with PCOS correlate with clinical and laboratory indices of hyperandrogenism and not with central obesity and insulin resistance.多囊卵巢综合征(PCOS)女性的抑郁、更高水平的紧张诱导以及对应激的应对策略受损,与高雄激素血症的临床和实验室指标相关,而与中心性肥胖和胰岛素抵抗无关。
Arch Womens Ment Health. 2025 Apr;28(2):339-348. doi: 10.1007/s00737-024-01500-x. Epub 2024 Aug 17.
5
Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome.多囊卵巢综合征病理生理学和治疗的细胞方法的最新进展。
Cells. 2023 Aug 31;12(17):2189. doi: 10.3390/cells12172189.
6
Differential Association of FTO Gene variants and Haplotypes with the Susceptibility to Polycystic Ovary Syndrome According To Obesity in Women with PCOS.根据多囊卵巢综合征患者的肥胖情况,FTO 基因变异和单倍型与多囊卵巢综合征易感性的关联存在差异。
Reprod Sci. 2023 Jul;30(7):2166-2176. doi: 10.1007/s43032-022-01149-w. Epub 2023 Jan 5.
7
Differentiating Polycystic Ovary Syndrome from Adrenal Disorders.多囊卵巢综合征与肾上腺疾病的鉴别
Diagnostics (Basel). 2022 Aug 24;12(9):2045. doi: 10.3390/diagnostics12092045.
8
The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report.一名绝经后女性患具有临床和生化高雄激素血症的莱迪希类固醇细胞瘤:病例报告
Metabolites. 2022 Jul 4;12(7):620. doi: 10.3390/metabo12070620.
9
Virilization by an Ovarian Tumor: Presentation Is Not Always Acute.卵巢肿瘤导致男性化:表现并不总是急性的。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096211056494. doi: 10.1177/23247096211056494.
10
Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.采用 LC-MS/MS 测定不同雄激素在反映高雄激素血症中的疗效比较及地塞米松抑制试验评估多囊卵巢综合征患者肾上腺源性雄激素。
J Ovarian Res. 2021 Feb 14;14(1):32. doi: 10.1186/s13048-021-00781-5.